AVTE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.90%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Aerovate Therapeutics Insider Trading History Chart

Aerovate Therapeutics Share Price & Price History

^$12.00

▲ +0.38 (3.27%)

As of 12/3/2025 01:00 AM ET

Days: 30 | 90 | 365

Aerovate Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/14/2024	George A Eldridge	Insider	Sell	428	$876.05	$374,949.40	143
5/17/2024	Hunter Gillies	Insider	Sell	114	$737.80	$84,109.20	160
5/16/2024	Timothy P. Noyes	CEO	Sell	285	$755.30	$215,260.50
5/2/2024	Marinus Verwijs	Insider	Sell	56	$735.70	$41,199.20
5/1/2024	Timothy P. Noyes	CEO	Sell	324	$711.90	$230,655.60
4/17/2024	Benjamin T Dake	Insider	Sell	195	$782.95	$152,675.25	36
4/16/2024	Timothy P. Noyes	CEO	Sell	285	$864.50	$246,382.50
4/10/2024	George A Eldridge	Insider	Sell	214	$939.75	$201,106.50	56
4/9/2024	David S Grayzel	Director	Sell	339	$985.25	$333,999.75	414
4/1/2024	Benjamin T Dake	Insider	Sell	95	$1,118.95	$106,300.25	36
4/1/2024	Timothy P. Noyes	CEO	Sell	285	$1,050.00	$299,250.00
3/27/2024	Benjamin T Dake	Insider	Sell	316	$978.95	$309,348.20	36
3/25/2024	Benjamin T Dake	Insider	Sell	98	$980.35	$96,074.30	36
3/19/2024	Marinus Verwijs	insider	Sell	151	$912.80	$137,832.80	36
3/13/2024	George A Eldridge	Insider	Sell	57	$875.70	$49,914.90	56
3/11/2024	George A Eldridge	Insider	Sell	98	$883.75	$86,607.50	56
3/8/2024	George A Eldridge	Insider	Sell	3	$875.00	$2,625.00	56
2/23/2024	Hunter Gillies	Insider	Sell	14	$682.50	$9,555.00	92
2/20/2024	Hunter Gillies	Insider	Sell	99	$708.05	$70,096.95	92
2/5/2024	Ralph Niven	Insider	Sell	131	$610.75	$80,008.25	45
1/17/2024	Hunter Gillies	Insider	Sell	114	$682.50	$77,805.00	92
1/5/2024	Ralph Niven	Insider	Sell	131	$670.60	$87,848.60	45
12/27/2023	Hunter Gillies	Insider	Sell	3	$857.50	$2,572.50	92
12/20/2023	Hunter Gillies	Insider	Sell	114	$682.50	$77,805.00	92
12/13/2023	Hunter Gillies	Insider	Sell	60	$682.50	$40,950.00	92
12/5/2023	Ralph Niven	Insider	Sell	131	$570.50	$74,735.50	45
11/27/2023	Benjamin T Dake	Insider	Sell	357	$568.40	$202,918.80	36
11/24/2023	Benjamin T Dake	Insider	Sell	142	$550.90	$78,227.80	36
11/22/2023	Benjamin T Dake	Insider	Sell	268	$530.95	$142,294.60	36
11/1/2023	Marinus Verwijs	CTO	Sell	27	$366.10	$9,884.70
11/1/2023	Timothy P. Noyes	CEO	Sell	31	$364.70	$11,305.70
9/6/2023	Benjamin T Dake	Insider	Sell	112	$527.10	$59,035.20	36
8/7/2023	Benjamin T Dake	Insider	Sell	293	$543.20	$159,157.60	36
7/28/2023	Timothy P. Noyes	CEO	Sell	156	$630.00	$98,280.00
7/17/2023	Timothy P. Noyes	CEO	Sell	129	$633.85	$81,766.65
7/6/2023	Benjamin T Dake	Insider	Sell	293	$583.10	$170,848.30	36
7/3/2023	Timothy P. Noyes	CEO	Sell	285	$630.00	$179,550.00
6/5/2023	Ralph Niven	Insider	Sell	64	$569.10	$36,422.40	45
5/19/2023	Hunter Gillies	Insider	Sell	1	$682.50	$682.50	92
5/17/2023	Hunter Gillies	Insider	Sell	31	$685.65	$21,255.15	92
5/8/2023	Benjamin T Dake	Insider	Sell	293	$763.00	$223,559.00	36
5/5/2023	Ralph Niven	Insider	Sell	64	$730.45	$46,748.80	45
5/3/2023	Marinus Verwijs	SVP	Sell	21	$727.65	$15,280.65
5/1/2023	Timothy P Noyes	CEO	Sell	428	$721.35	$308,737.80	19
4/21/2023	Hunter Gillies	Insider	Sell	114	$682.50	$77,805.00	56
4/6/2023	Benjamin T. Dake	insider	Sell	293	$635.95	$186,333.35	45
4/3/2023	Timothy P. Noyes	CEO	Sell	428	$678.65	$290,462.20
3/6/2023	Benjamin T. Dake	insider	Sell	293	$830.55	$243,351.15	45
3/1/2023	Timothy P. Noyes	CEO	Sell	428	$833.35	$356,673.80
2/6/2023	Benjamin T. Dake	insider	Sell	293	$860.65	$252,170.45	45
2/1/2023	Timothy P. Noyes	CEO	Sell	428	$793.80	$339,746.40
1/6/2023	Benjamin T. Dake	insider	Sell	293	$909.30	$266,424.90	45
1/3/2023	Timothy P. Noyes	CEO	Sell	428	$947.45	$405,508.60
12/12/2022	George A Eldridge	Insider	Sell	285	$1,051.40	$299,649.00	56
12/8/2022	George A Eldridge	Insider	Sell	343	$835.45	$286,559.35	56
12/5/2022	Ralph Niven	Insider	Sell	64	$608.30	$38,931.20	45

SEC Filings (Institutional Ownership Changes) for Aerovate Therapeutics (NASDAQ:AVTE)

Institutional Buying and Selling by Quarter

Aerovate Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/27/2025	Goldman Sachs Group Inc.	352,669	$0.89M	0.0%	+12.2%	1.217%
5/29/2025	Rhumbline Advisers	22,750	$57K	0.0%	+67.3%	0.078%
5/21/2025	Acadian Asset Management LLC	15,980	$40K	0.0%	-81.4%	0.055%
5/19/2025	Jane Street Group LLC	11,009	$28K	0.0%	N/A	0.038%
5/16/2025	Goldman Sachs Group Inc.	352,669	$0.89M	0.0%	+12.2%	1.217%
5/16/2025	AQR Capital Management LLC	21,633	$54K	0.0%	+14.7%	0.075%
5/16/2025	Allostery Investments LP	1,421,568	$3.57M	5.1%	+67.1%	4.904%
5/16/2025	ADAR1 Capital Management LLC	1,461,234	$3.67M	0.7%	+57.5%	5.041%
5/13/2025	Kovitz Investment Group Partners LLC	26,514	$67K	0.0%	N/A	0.091%
5/13/2025	Russell Investments Group Ltd.	32,395	$81K	0.0%	+113.3%	0.112%
5/12/2025	Nuveen LLC	40,047	$0.10M	0.0%	N/A	0.138%
5/12/2025	Invesco Ltd.	74,440	$0.19M	0.0%	N/A	0.257%
5/9/2025	PNC Financial Services Group Inc.	13,962	$35K	0.0%	+8,210.7%	0.048%
5/8/2025	XTX Topco Ltd	18,739	$47K	0.0%	-21.1%	0.065%
4/22/2025	Deltec Asset Management LLC	361,804	$0.91M	0.2%	+86.4%	1.248%
4/8/2025	Rhumbline Advisers	22,750	$57K	0.0%	+67.3%	0.078%
2/27/2025	Jefferies Financial Group Inc.	600,000	$1.59M	0.0%	N/A	2.078%
2/18/2025	GTS Securities LLC	10,082	$27K	0.0%	N/A	0.035%
2/17/2025	Squarepoint Ops LLC	19,564	$52K	0.0%	N/A	0.068%
2/17/2025	Two Sigma Advisers LP	153,600	$0.41M	0.0%	+38.5%	0.532%
2/17/2025	Two Sigma Investments LP	226,121	$0.60M	0.0%	-27.8%	0.783%
2/17/2025	Millennium Management LLC	65,698	$0.17M	0.0%	-66.6%	0.228%
2/17/2025	Jefferies Financial Group Inc.	600,000	$1.59M	0.0%	N/A	2.078%
2/17/2025	Bridgeway Capital Management LLC	60,000	$0.16M	0.0%	N/A	0.208%
2/17/2025	Braidwell LP	1,440,499	$3.82M	0.1%	N/A	4.989%
2/17/2025	Blackstone Inc.	499,566	$1.32M	0.0%	N/A	1.730%
2/17/2025	Bank of America Corp DE	231,085	$0.61M	0.0%	-11.5%	0.800%
2/17/2025	BNP Paribas Financial Markets	54,688	$0.15M	0.0%	N/A	0.189%
2/17/2025	Allostery Investments LP	850,684	$2.25M	2.3%	N/A	2.946%
2/14/2025	Nantahala Capital Management LLC	482,928	$1.28M	0.1%	N/A	1.672%
2/14/2025	Northern Trust Corp	106,692	$0.28M	0.0%	+6.3%	0.369%
2/14/2025	Vazirani Asset Management LLC	75,000	$0.20M	0.6%	N/A	0.260%
2/14/2025	Harvest Investment Services LLC	23,919	$63K	0.0%	N/A	0.083%
2/13/2025	Affinity Asset Advisors LLC	800,000	$2.12M	0.3%	+33.3%	2.770%
2/13/2025	XTX Topco Ltd	23,745	$63K	0.0%	N/A	0.082%
2/13/2025	Scotia Capital Inc.	37,210	$99K	0.0%	N/A	0.129%
2/13/2025	Renaissance Technologies LLC	44,600	$0.12M	0.0%	+149.2%	0.154%
2/13/2025	ADAR1 Capital Management LLC	928,016	$2.46M	0.5%	+720.7%	3.213%
2/13/2025	Bank of Montreal Can	59,097	$0.16M	0.0%	+86.8%	0.205%
2/13/2025	Russell Investments Group Ltd.	15,184	$40K	0.0%	+110.7%	0.053%
2/12/2025	JPMorgan Chase & Co.	67,165	$0.18M	0.0%	+1,021.1%	0.233%
2/10/2025	Corient Private Wealth LLC	36,897	$98K	0.0%	N/A	0.128%
2/3/2025	Ieq Capital LLC	14,377	$38K	0.0%	N/A	0.050%
1/27/2025	Deltec Asset Management LLC	194,124	$0.51M	0.1%	N/A	0.672%
1/13/2025	FNY Investment Advisers LLC	75,000	$0.20M	0.1%	N/A	0.260%
11/19/2024	Barclays PLC	18,972	$39K	0.0%	+310.8%	0.066%
11/16/2024	Geode Capital Management LLC	291,887	$0.61M	0.0%	-8.0%	1.011%
11/15/2024	Barclays PLC	18,972	$39K	0.0%	+310.8%	0.066%
11/15/2024	Jane Street Group LLC	17,805	$37K	0.0%	-86.0%	0.062%
11/15/2024	State Street Corp	367,468	$0.77M	0.0%	+7.7%	1.272%
11/14/2024	Verition Fund Management LLC	99,815	$0.21M	0.0%	-59.9%	0.346%
11/13/2024	FMR LLC	82,919	$0.17M	0.0%	+54,095.4%	0.287%
11/12/2024	Charles Schwab Investment Management Inc.	29,351	$61K	0.0%	-43.7%	0.102%
11/5/2024	GSA Capital Partners LLP	413,795	$0.87M	0.1%	+226.8%	1.433%
9/16/2024	Cubist Systematic Strategies LLC	31,894	$53K	0.0%	N/A	0.111%
8/15/2024	Deerfield Management Company L.P. Series C	1,411,608	$2.34M	0.0%	N/A	4.898%
8/15/2024	Affinity Asset Advisors LLC	200,000	$0.33M	0.0%	N/A	0.694%
8/14/2024	Cubist Systematic Strategies LLC	31,894	$53K	0.0%	N/A	0.111%
8/12/2024	XTX Topco Ltd	21,143	$35K	0.0%	N/A	0.073%
8/9/2024	Atlas Venture Life Science Advisors LLC	1,799,232	$2.99M	0.3%	-11.8%	6.243%
8/9/2024	Warberg Asset Management LLC	67,449	$0.11M	0.0%	N/A	0.234%
8/6/2024	Quest Partners LLC	32,856	$55K	0.0%	+610.2%	0.114%
7/26/2024	Bank of New York Mellon Corp	46,988	$78K	0.0%	+69.9%	0.163%
7/19/2024	Values First Advisors Inc.	15,381	$26K	0.0%	N/A	0.053%
7/12/2024	SG Americas Securities LLC	179,493	$0.30M	0.0%	N/A	0.623%
5/17/2024	Ikarian Capital LLC	367,965	$10.88M	1.2%	N/A	1.277%
5/16/2024	California State Teachers Retirement System	1,124	$33K	0.0%	-38.9%	0.004%
5/14/2024	EntryPoint Capital LLC	3,126	$92K	0.1%	-49.0%	0.011%
5/10/2024	Vanguard Group Inc.	672,275	$19.88M	0.0%	+7.2%	2.410%
2/20/2024	Eventide Asset Management LLC	12,178	$0.28M	0.0%	N/A	0.044%
2/15/2024	Octagon Capital Advisors LP	403,685	$9.14M	1.5%	-18.8%	1.459%
2/15/2024	Parkwood LLC	15,786	$0.36M	0.0%	-23.6%	0.057%
2/15/2024	Great Point Partners LLC	1,037,690	$23.48M	4.0%	-4.9%	3.750%
2/14/2024	Vestal Point Capital LP	400,000	$9.05M	1.0%	N/A	1.446%
11/15/2023	Alps Advisors Inc.	20,395	$0.28M	0.0%	+11.3%	0.074%
11/14/2023	Fred Alger Management LLC	24,747	$0.34M	0.0%	-57.2%	0.090%
11/13/2023	Silverarc Capital Management LLC	100,000	$1.36M	0.4%	N/A	0.362%
11/13/2023	FMR LLC	529,544	$7.19M	0.0%	-27.2%	1.915%
11/8/2023	Swiss National Bank	21,201	$0.29M	0.0%	+30.9%	0.077%
9/21/2023	Barclays PLC	3,406	$58K	0.0%	-27.8%	0.012%
8/15/2023	HighVista Strategies LLC	41,803	$0.72M	0.3%	+164.0%	0.151%
8/14/2023	Great Point Partners LLC	932,158	$15.99M	3.1%	+23.4%	3.377%
8/14/2023	TCG Crossover Management LLC	2,201,274	$37.75M	6.2%	+103.6%	7.976%
8/14/2023	Driehaus Capital Management LLC	1,194,091	$20.48M	0.3%	N/A	4.326%
7/31/2023	Strs Ohio	2,300	$39K	0.0%	N/A	0.008%
6/1/2023	Golden State Equity Partners	10,530	$0.21M	0.1%	N/A	0.042%
5/16/2023	Great Point Partners LLC	755,620	$15.24M	3.0%	+99.6%	3.046%
5/16/2023	Atlas Venture Life Science Advisors LLC	2,039,249	$41.13M	5.6%	+1.1%	8.219%
5/16/2023	Baker BROS. Advisors LP	1,963,479	$39.60M	0.2%	-0.7%	7.914%
5/15/2023	Ghost Tree Capital LLC	200,000	$4.03M	1.2%	+48.1%	0.806%
5/12/2023	Nan Fung Group Holdings Ltd	47,936	$0.97M	0.7%	-5.3%	0.193%
5/11/2023	Skandinaviska Enskilda Banken AB publ	50,866	$1.03M	0.0%	-4.6%	0.205%
3/23/2023	MetLife Investment Management LLC	5,228	$0.15M	0.0%	N/A	0.021%
2/15/2023	Eversept Partners LP	91,252	$2.67M	0.2%	N/A	0.374%
2/15/2023	Atlas Venture Life Science Advisors LLC	2,017,521	$59.11M	7.1%	-13.3%	8.265%
2/15/2023	Nantahala Capital Management LLC	15,700	$0.46M	0.0%	N/A	0.064%
2/14/2023	VR Adviser LLC	747,869	$21.91M	3.5%	-10.3%	3.064%
2/14/2023	Parkwood LLC	20,560	$0.60M	0.1%	-3.7%	0.084%
2/10/2023	Cheyne Capital Management UK LLP	18,927	$0.56M	1.0%	N/A	0.078%
2/8/2023	Skandinaviska Enskilda Banken AB publ	53,340	$1.56M	0.0%	-5.5%	0.219%

Data available starting January 2016

Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which is in Phase 2b/Phase 3 trial. The company was incorporated in 2018 and is headquartered in Waltham, Massachusetts.

Today's Range

Now: $12.00

$11.32

$12.40

50 Day Range

MA: $10.13

$8.06

$12.82

52 Week Range

Now: $12.00

$56.35

$105.00

Volume

246,525 shs

Average Volume

12,438 shs

Market Capitalization

$347.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.95

Who are the company insiders with the largest holdings of Aerovate Therapeutics?: Aerovate Therapeutics' top insider shareholders include:
David S Grayzel (Director)
Hunter Gillies (Insider)
George A Eldridge (Insider)
Ralph Niven (Insider)
Benjamin T Dake (Insider)
Marinus Verwijs (Insider)
Timothy P Noyes (CEO)
Learn More about top insider investors at Aerovate Therapeutics.